Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.

Researchers sought to determine whether adding nivolumab to AVD would be an effective treatment for older patients with classic HL.

In the phase 2 EXTEND trial, investigators randomly assigned patients with oligometastatic prostate cancer to ADT or MDT + ADT, with further stratification by intermittent vs continuous ADT that was ...

Researchers sought to determine whether VRD induction would be effective and tolerable for transplant-eligible patients with NDMM.

HealthDay News — Rural residents with colon cancer are significantly less likely to undergo minimally invasive surgery (MIS) and significantly more likely to experience worse outcomes compared with ...

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.